The symposium will be held at the Vancouver General Hospital, Paetzold Auditorium, 899 W 12th Avenue, Vancouver BC V5Z 1M9, Canada.
Participation in this ACHI approved symposium offers 1.65 CECs.
Symposium agenda outline is below. Talks in Bold Italic will NOT be available as recordings afterwards (status Dec 1, 2024 - more may be included later)
Detailed agenda with exact timings for all talks can be downloaded here (FINAL agenda, posted December 1)
Monday, December 2, 2024
| 8.30 | Registration opens |
| 9.00 - 9.20 | Opening session Karen Sherwood (UBC): Welcome address Julia Hill (Genome BC): From the Funder's Perspective: Genome BC and the CanPrevent Initiative |
| 9.20 - 10.35 | Session 1 CanPREV Wrap up Activity 1 - “Improving Donor Matching” MODERATOR Karen Sherwood Paul Keown (UBC): Status of Kidney Transplants from 2008 to Today Ruth Sapir-Pichhadze (McGill): Incorporating Molecular Compatibility in Organ Allocation Schemes: From Knowledge Generation to Implementation Industry spotlight GenDx: Andrew Meyers, Sr Sales & Application Specialist / Education Manger, North America, GenDx |
| 10.35 - 11.05 | Morning coffee break - 30 minutes - sponsored by:  |
| 11.05 - 12.20 | Session 2 CanPREV Wrap up Activities 2 & 3 -”Immune monitoring” & “Personalizing Treatments” MODERATOR Sarah Grasedieck Michael Oellerich (University of Goettingen, DE): Donor-derived cell-free DNA for personalized immunosuppression in transplantation James Lan (UBC): Implementation of Eplet Mismatch Analysis to Inform Induction Therapy in Kidney Transplantation Industry spotlight: Chris McCloskey, Executive VP, Transplant Services & Business Development, PIRCHE AG |
| 12.20 - 13.20 | Lunch - 60 minutes - sponsored by:  |
| 13.20 - 14.35 | Session 3 CanPREV Wrap up of Activity 4 - “Health Policy Decisions” MODERATOR Timothy Caulfield Shahzad Ghanbarian (UBC): Analytical Infrastructure to Guide Kidney Transplantation Policy: A Discrete Event Simulation Approach to Evaluate Kidney Allocation Strategies Louisa Edwards (UBC): Informing policymaking on epitope/eplet matching in kidney transplantation: Public deliberation and economic modelling Marie-Chantal Fortin (CHUM): Stakeholders' Perspectives on Precision Medicine in Organ Allocation |
| 14.35 - 15.05 | Afternoon break – 30 minutes |
| 15.05 - 16.15 | Session 4 CanPREV Wrap up discussion MODERATOR Paul Keown Timothy Caulfield (UAlberta): Precision Health: From Good Science to Scienc-y Marketing Hype? Activity leads |
| 16.15 - 18.00 |
Exhibition opens, reception Exhibitors:   
   
 
|
| 18.00 | End of Day 1 |
Tuesday, December 3, 2024
| 8.30 – 9.00 | Arrival, Exhibition open |
| 9.00 - 10.35 | Session 5 Canadian Molecular Matching Program (CMMP) - Activities 1 & 2 MODERATOR Jenny Tran Ahmed Mostafa (University of Saskatchewan): Transforming Kidney Transplant Outcomes: Advanced In Silico Analysis for Predicting Graft Failure Klemens Budde (Charité, Germany): New treatment options for antibody mediated rejection Dimitri Monos (CHOP, USA): Optimizing the matching process for donor selection in solid organ transplantation Industry Spotlight - Gordon Hill, VP, Transplant Laboratory Solutions, Americas, CareDx |
| 10.35 - 11.05 | Morning coffee break - 30 min - sponsored by  |
| 11.05 - 12.40 | Session 6 Canadian Molecular Matching Program (CMMP) - Activities 3 & 4 MODERATOR Franz Fenninger Paul Keown (UBC): Clinical Trial Design Megan Levings (BCCHR): Inducing tolerance with regulatory T-cells Michael Mengel (University of Alberta): Spatial Biology: Deciphering molecular phenotypes in allograft biopsies Industry spotlight - Adriana Suarez, Science and Technology Advisor, 10xGenomics |
| 12.40 - 13.40 | Lunch - 60 min - sponsored by  |
| 13.40 - 15.15 | Session 7 Tolerance / Future Plans MODERATOR Michael Barnett Kirk Schultz (UBC): Pathways to Primary and Secondary Immune Tolerance after HSCT Dean Regier (UBC): Regulatory Science: Accelerating Health, Economic, and Policy Innovation David Sweet (patient partner): HLA Matching and Immunosuppression--a personal perspective Lisa Ridgway (patient partner): A Journey Unlike Any Other: Patient Engagement in Pharmacogenomics |
| 15.15 - 15.45 | Afternoon break – 30 min |
| 15.45 - 16.30 | Closing Session - MODERATOR Paul Keown Panel discussion |
16.30 17.00 | End of Symposium Exhibition closes |